Insider Transactions in Q2 2022 at Bausch Health Companies Inc. (BHC)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2022
|
John Paulson Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,251
+1.79%
|
$18,008
$8.36 P/Share
|
|
Jun 30
2022
|
Russel C Robertson Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,560
+2.65%
|
$36,480
$8.36 P/Share
|
|
Jun 30
2022
|
Amy B Wechsler Director |
BUY
Grant, award, or other acquisition
|
Direct |
822
+0.61%
|
$6,576
$8.36 P/Share
|
|
Jun 30
2022
|
Steven D Miller Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,663
+3.49%
|
$29,304
$8.36 P/Share
|
|
Jun 30
2022
|
Brett Icahn Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,663
+6.68%
|
$29,304
$8.36 P/Share
|
|
Jun 30
2022
|
Richard U De Schutter Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,111
+1.13%
|
$32,888
$8.36 P/Share
|
|
Jun 24
2022
|
Richard Mulligan Director |
BUY
Grant, award, or other acquisition
|
Direct |
34,387
+48.37%
|
-
|
|
Jun 24
2022
|
Argeris N Karabelas Director |
BUY
Grant, award, or other acquisition
|
Direct |
34,387
+21.75%
|
-
|
|
Jun 24
2022
|
Richard U De Schutter Director |
BUY
Grant, award, or other acquisition
|
Direct |
34,387
+8.82%
|
-
|
|
Jun 24
2022
|
Brett Icahn Director |
BUY
Grant, award, or other acquisition
|
Direct |
34,387
+42.0%
|
-
|
|
Jun 24
2022
|
Amy B Wechsler Director |
BUY
Grant, award, or other acquisition
|
Direct |
34,387
+20.45%
|
-
|
|
Jun 24
2022
|
Thomas W. Ross Sr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
34,387
+20.63%
|
-
|
|
Jun 24
2022
|
Russel C Robertson Director |
BUY
Grant, award, or other acquisition
|
Direct |
34,387
+17.45%
|
-
|
|
Jun 24
2022
|
Robert N Power Director |
BUY
Grant, award, or other acquisition
|
Direct |
34,387
+20.2%
|
-
|
|
Jun 24
2022
|
John Paulson Director |
BUY
Grant, award, or other acquisition
|
Direct |
34,387
+22.13%
|
-
|
|
Jun 24
2022
|
Steven D Miller Director |
BUY
Grant, award, or other acquisition
|
Direct |
34,387
+26.05%
|
-
|
|
Jun 24
2022
|
Sarah B Kavanagh Director |
BUY
Grant, award, or other acquisition
|
Direct |
34,387
+22.65%
|
-
|
|
Jun 20
2022
|
John S Barresi SVP, Controller & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
16,898
+50.0%
|
-
|
|
May 13
2022
|
Richard Mulligan Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,317
+50.0%
|
-
|
|
May 10
2022
|
Thomas Appio Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
32,022
+3.1%
|
-
|
|
May 10
2022
|
Robert Spurr President, U.S. Businesses |
BUY
Exercise of conversion of derivative security
|
Direct |
22,235
+9.39%
|
-
|
|
May 10
2022
|
Joseph C Papa Director |
SELL
Payment of exercise price or tax liability
|
Direct |
33,714
-2.31%
|
$303,426
$9.4 P/Share
|
|
May 10
2022
|
Joseph C Papa Director |
BUY
Exercise of conversion of derivative security
|
Direct |
366,130
+8.24%
|
-
|
|
May 10
2022
|
Seana Carson EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
7,467
+4.78%
|
-
|
|
May 03
2022
|
Frederick Munsch SVP, Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
747
-3.22%
|
$13,446
$18.66 P/Share
|
|
Apr 14
2022
|
Robert Spurr President, U.S. Businesses |
SELL
Open market or private sale
|
Direct |
1,595
-1.73%
|
$35,090
$22.19 P/Share
|